Caption Management, LLC Eye Point Pharmaceuticals, Inc. Call Options Transaction History

Caption Management, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$19.93 - $29.71 $265,069 - $395,143	-13,300 Reduced 8.87%	136,700 $2.83 Million
Q4 2023 Feb 14, 2024	BUY	$5.71 - $24.13 $856,500 - $3.62 Million	150,000 New	150,000 $3.47 Million
Q2 2022 Aug 15, 2022	SELL	$7.25 - $12.71 $362,500 - $635,500	-50,000 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$8.67 - $14.11 $2.75 Million - $4.47 Million	-316,700 Reduced 86.36%	50,000 $608,000
Q4 2021 Feb 11, 2022	BUY	$10.18 - $18.4 $1.78 Million - $3.22 Million	175,100 Added 91.39%	366,700 $4.49 Million
Q3 2021 Nov 12, 2021	BUY	$7.51 - $11.72 $1.44 Million - $2.25 Million	191,600 New	191,600 $2 Million

150

58M

177K

263K

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $312M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.